EGFR and non-small cell lung carcinoma: On the other hand, using a rabbit polyclonal anti-PD-L1 antibody and a median histological score value of 30 as the cutoff point, the presence of EGFR mutations was found to be associated with increased PD-L1 expression in Japanese NSCLC patients [43].